AIMS/HYPOTHESIS: Adenosine is an important regulator of metabolism; however, the role of the A1 receptor during ageing and obesity is unclear. The aim of this study was to investigate the effects of A1 signalling in modulating metabolic function during ageing. METHODS: Age-matched young and aged A 1 (also known as Adora1)-knockout (A1(-/-)) and wild-type (A1(+/+)) mice were used. Metabolic regulation was evaluated by body composition, and glucose and insulin tolerance tests. Isolated islets and islet arterioles were used to detect islet endocrine and vascular function. Oxidative stress and inflammation status were measured in metabolic organs and systemically. RESULTS: Advanced age was associated with both reduced glucose clearance and insulin sensitivity, as well as increased visceral adipose tissue (VAT) in A1(+/+) compared with A1(-/-) mice. Islet morphology and insulin content were similar between genotypes, but relative changes in in vitro insulin release following glucose stimulation were reduced in aged A1(+/+) compared with A1(-/-) mice. Islet arteriolar responses to angiotensin II were stronger in aged A1(+/+) mice, this being associated with increased NADPH oxidase activity. Ageing resulted in multiple changes in A1(+/+) compared with A1(-/-) mice, including enhanced NADPH oxidase-derived O2(-) formation and NADPH oxidase isoform 2 (Nox2) protein expression in pancreas and VAT; elevated levels of circulating insulin, leptin and proinflammatory cytokines (TNF-α, IL-1β, IL-6 and IL-12); and accumulation of CD4(+) T cells in VAT. This was associated with impaired insulin signalling in VAT from aged A1(+/+) mice. CONCLUSIONS/ INTERPRETATION: These studies emphasise that A1 receptors regulate metabolism and islet endocrine and vascular functions during ageing, including via the modulation of oxidative stress and inflammatory responses, among other things.
AIMS/HYPOTHESIS: Adenosine is an important regulator of metabolism; however, the role of the A1 receptor during ageing and obesity is unclear. The aim of this study was to investigate the effects of A1 signalling in modulating metabolic function during ageing. METHODS: Age-matched young and aged A 1 (also known as Adora1)-knockout (A1(-/-)) and wild-type (A1(+/+)) mice were used. Metabolic regulation was evaluated by body composition, and glucose and insulin tolerance tests. Isolated islets and islet arterioles were used to detect islet endocrine and vascular function. Oxidative stress and inflammation status were measured in metabolic organs and systemically. RESULTS: Advanced age was associated with both reduced glucose clearance and insulin sensitivity, as well as increased visceral adipose tissue (VAT) in A1(+/+) compared with A1(-/-) mice. Islet morphology and insulin content were similar between genotypes, but relative changes in in vitro insulin release following glucose stimulation were reduced in aged A1(+/+) compared with A1(-/-) mice. Islet arteriolar responses to angiotensin II were stronger in aged A1(+/+) mice, this being associated with increased NADPH oxidase activity. Ageing resulted in multiple changes in A1(+/+) compared with A1(-/-) mice, including enhanced NADPH oxidase-derived O2(-) formation and NADPH oxidase isoform 2 (Nox2) protein expression in pancreas and VAT; elevated levels of circulating insulin, leptin and proinflammatory cytokines (TNF-α, IL-1β, IL-6 and IL-12); and accumulation of CD4(+) T cells in VAT. This was associated with impaired insulin signalling in VAT from aged A1(+/+) mice. CONCLUSIONS/ INTERPRETATION: These studies emphasise that A1 receptors regulate metabolism and islet endocrine and vascular functions during ageing, including via the modulation of oxidative stress and inflammatory responses, among other things.
Authors: Bertil B Fredholm; Adriaan P IJzerman; Kenneth A Jacobson; Joel Linden; Christa E Müller Journal: Pharmacol Rev Date: 2011-02-08 Impact factor: 25.468
Authors: Stina M Johansson; Eva Lindgren; Jiang-Ning Yang; Andreas W Herling; Bertil B Fredholm Journal: Eur J Pharmacol Date: 2008-08-31 Impact factor: 4.432
Authors: Yi Zheng; Qijing Lei; Aldo Jongejan; Callista L Mulder; Saskia K M van Daalen; Sebastiaan Mastenbroek; Grace Hwang; Philip W Jordan; Sjoerd Repping; Geert Hamer Journal: DNA Repair (Amst) Date: 2018-08-28
Authors: Ruzanna Shkhyan; Siyoung Lee; Francesca Gullo; Lei Li; Maria Peleli; Mattias Carlstrom; Andrei S Chagin; Nicholas W Banks; Sean Limfat; Nancy Q Liu; Denis Evseenko Journal: J Mol Med (Berl) Date: 2018-08-07 Impact factor: 4.599
Authors: Michael P Hezel; Ming Liu; Tomas A Schiffer; Filip J Larsen; Antonio Checa; Craig E Wheelock; Mattias Carlström; Jon O Lundberg; Eddie Weitzberg Journal: Redox Biol Date: 2015-05-29 Impact factor: 11.799
Authors: Ting Yang; Christa Zollbrecht; Malin E Winerdal; Zhengbing Zhuge; Xing-Mei Zhang; Niccolo Terrando; Antonio Checa; Johan Sällström; Craig E Wheelock; Ola Winqvist; Robert A Harris; Erik Larsson; A Erik G Persson; Bertil B Fredholm; Mattias Carlström Journal: J Am Heart Assoc Date: 2016-07-18 Impact factor: 5.501
Authors: Maria Peleli; Michael Hezel; Christa Zollbrecht; A Erik G Persson; Jon O Lundberg; Eddie Weitzberg; Bertil B Fredholm; Mattias Carlström Journal: Front Physiol Date: 2015-08-07 Impact factor: 4.566
Authors: Leif Jansson; Andreea Barbu; Birgitta Bodin; Carl Johan Drott; Daniel Espes; Xiang Gao; Liza Grapensparr; Örjan Källskog; Joey Lau; Hanna Liljebäck; Fredrik Palm; My Quach; Monica Sandberg; Victoria Strömberg; Sara Ullsten; Per-Ola Carlsson Journal: Ups J Med Sci Date: 2016-04-28 Impact factor: 2.384